ASPERCREME LIDOCAINE NO-MESS BERGAMOT ORANGE- lidocaine hydrochloride liquid 
Chattem, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Aspercreme with Lidocaine No-Mess Bergamot Orange

ASPERCREME LIDOCAINE WITH BERGAMOT NO-MESS

Drug Facts

Active ingredient

Lidocaine HCl 4%

Purpose

Topical anesthetic

Use  

temporarily relieves minor pain

Warnings

For external use only

Do not use 

■ on large areas of the body or on cut, irritated or swollen skin

■ on puncture wounds 

■ for more than one week without consulting a doctor 

When using this product

■ use only as directed. Read and follow all directions and warnings on this carton.

■ do not allow contact with the eyes and mucous membranes

■ do not bandage or apply local heat (such as heating pads) or a medicated patch to the area of use

■ do not use at the same time as other topical analgesics  

Stop use and ask a doctor if

■ condition worsens

■ redness is present

■ irritation develops

■ symptoms persist for more than 7 days or clear up and occur again within a few days

Flammable  ■ Keep away from fire or flame

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

adults and children over 12 years:

■ apply a thin layer to affected area every 6 to 8 hours, not to exceed 3 applications in a 24 hour period

children 12 years or younger: ask a doctor

Inactive ingredients

acrylates/C10-30 alkyl acrylate crosspolymer, alcohol denat. (15%), aloe barbadensis leaf juice, aminomethyl propanol, C30-45 alkyl cetearyl dimethicone crosspolymer, caprylyl methicone, cetearyl alcohol, ceteth-20 phosphate, citrus aurantium bergamia (bergamot) fruit oil, dicetyl phosphate, dimethicone, disodium EDTA, ethylhexylglycerin, glyceryl stearate, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, isohexadecane, methylparaben, polysorbate 60, steareth-2, steareth-21, water

Child-resistant packaging. Close cap tightly after use.

Keep carton as it contains important information.

Principal Display Panel

MAX STRENGTH
Aspercreme
WITH 4% LIDOCAINE
infused with ESSENTIAL OIL
2.5 fl oz (73 mL)

Principal Display Panel NEW MAX STRENGTH Aspercreme WITH 4% LIDOCAINE infused with ESSENTIAL OIL 2.5 fl oz (73 mL)

ASPERCREME LIDOCAINE NO-MESS BERGAMOT ORANGE 
lidocaine hydrochloride liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:41167-0590
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A) (LIDOCAINE - UNII:98PI200987) LIDOCAINE HYDROCHLORIDE ANHYDROUS4 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED) (UNII: 59TL3WG5CO)  
ALCOHOL (UNII: 3K9958V90M)  
ALOE VERA LEAF (UNII: ZY81Z83H0X)  
AMINOMETHYLPROPANOL (UNII: LU49E6626Q)  
CAPRYLYL TRISILOXANE (UNII: Q95M2P1KJL)  
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
CETETH-20 PHOSPHATE (UNII: 921FTA1500)  
BERGAMOT OIL (UNII: 39W1PKE3JI)  
DIHEXADECYL PHOSPHATE (UNII: 2V6E5WN99N)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM)  
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%) (UNII: 86FQE96TZ4)  
ISOHEXADECANE (UNII: 918X1OUF1E)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
POLYSORBATE 60 (UNII: CAL22UVI4M)  
STEARETH-2 (UNII: V56DFE46J5)  
STEARETH-21 (UNII: 53J3F32P58)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:41167-0590-01 in 1 CARTON01/20/2020
173 mL in 1 BOTTLE, WITH APPLICATOR; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH NOT FINALpart34801/20/2020
Labeler - Chattem, Inc. (003336013)

Revised: 1/2021
Document Id: 2b200450-fe7b-4ea8-a62d-4ad2cec66487
Set id: 5aac1c7b-6839-4f08-8192-ddc586fd4785
Version: 3
Effective Time: 20210125
 
Chattem, Inc.